These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 17093355

  • 21. Injectable contraception: the USA perspective.
    Kaunitz AM.
    IPPF Med Bull; 1992 Dec; 26(6):1-3. PubMed ID: 12346920
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Endometrial expression of epithelial neutrophil-activating peptide-78 during the menstrual cycle or in progestin-only contraceptive users with breakthrough bleeding and the influence of doxycycline therapy.
    Chegini N, Luo X, Pan Q, Rhoton-Vlasak A, Archer DF.
    Hum Reprod; 2007 Feb; 22(2):427-33. PubMed ID: 17095519
    [Abstract] [Full Text] [Related]

  • 25. Preventing repeat teen pregnancy: postpartum depot medroxyprogesterone acetate, oral contraceptive pills, or the patch?
    Thurman AR, Hammond N, Brown HE, Roddy ME.
    J Pediatr Adolesc Gynecol; 2007 Apr; 20(2):61-5. PubMed ID: 17418388
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Low-dose oral contraceptive to re-induce menstrual bleeding in amenorrheic women on DMPA treatment: a randomized clinical trial.
    Sadeghi-Bazargani H, Ehdaeivand F, Arshi S, Eftekhar H, Sezavar H, Amanati L.
    Med Sci Monit; 2006 Oct; 12(10):CR420-5. PubMed ID: 17006401
    [Abstract] [Full Text] [Related]

  • 28. Usefulness of FSH measurements for determining menopause in long-term users of depot medroxyprogesterone acetate over 40 years of age.
    Juliato CT, Fernandes A, Marchi NM, Castro S, Olivotti B, Bahamondes L.
    Contraception; 2007 Oct; 76(4):282-6. PubMed ID: 17900438
    [Abstract] [Full Text] [Related]

  • 29. Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density.
    Kaunitz AM, Darney PD, Ross D, Wolter KD, Speroff L.
    Contraception; 2009 Jul; 80(1):7-17. PubMed ID: 19501210
    [Abstract] [Full Text] [Related]

  • 30. Bone mineral density in women using depot medroxyprogesterone acetate (DMPA) for at least 2 years compared to a control group: a cross sectional study.
    Pongsatha S, Ekmahachai M, Chaovisitsaree S, Suntornlimsiri N, Morakote N.
    J Med Assoc Thai; 2009 Oct; 92(10):1263-7. PubMed ID: 19845231
    [Abstract] [Full Text] [Related]

  • 31. Comparison of the effects of the levonorgestrel-releasing intrauterine system (Mirena) and depot-medroxyprogesterone acetate (Depo-Provera) on subendometrial microvascularisation and uterine artery blood flow.
    Dane B, Akca A, Dane C, Evcimen S, Cetin A.
    Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):240-4. PubMed ID: 19565422
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Depo Now: preventing unintended pregnancies among adolescents and young adults.
    Rickert VI, Tiezzi L, Lipshutz J, León J, Vaughan RD, Westhoff C.
    J Adolesc Health; 2007 Jan; 40(1):22-8. PubMed ID: 17185202
    [Abstract] [Full Text] [Related]

  • 34. [Evaluation of safety in Chinese women with amenorrhea following injection of depot-medroxyprogesterone for contraception].
    Zhu M, Lei Z, Yang D.
    Zhonghua Fu Chan Ke Za Zhi; 1999 Oct; 34(10):621-3. PubMed ID: 11477805
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate.
    Sanches L, Marchi NM, Castro S, Juliato CT, Villarroel M, Bahamondes L.
    Contraception; 2008 Nov; 78(5):365-9. PubMed ID: 18929732
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Depot-medroxyprogesterone acetate: an update.
    Bakry S, Merhi ZO, Scalise TJ, Mahmoud MS, Fadiel A, Naftolin F.
    Arch Gynecol Obstet; 2008 Jul; 278(1):1-12. PubMed ID: 18470526
    [Abstract] [Full Text] [Related]

  • 40. Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain.
    Schlaff WD, Carson SA, Luciano A, Ross D, Bergqvist A.
    Fertil Steril; 2006 Feb; 85(2):314-25. PubMed ID: 16595206
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.